ATC code C10
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
A section of the Anatomical Therapeutic Chemical Classification System.
Lipid modifying agents, plain
C10AA HMG CoA reductase inhibitors
- C10AA01 Simvastatin
- C10AA02 Lovastatin
- C10AA03 Pravastatin
- C10AA04 Fluvastatin
- C10AA05 Atorvastatin
- C10AA06 Cerivastatin
- C10AA07 Rosuvastatin
- C10AA08 Pitavastatin
C10AB Fibrates
- C10AB01 Clofibrate
- C10AB02 Bezafibrate
- C10AB03 Aluminium clofibrate
- C10AB04 Gemfibrozil
- C10AB05 Fenofibrate
- C10AB06 Simfibrate
- C10AB07 Ronifibrate
- C10AB08 Ciprofibrate
- C10AB09 Etofibrate
- C10AB10 Clofibride
C10AC Bile acid sequestrants
- C10AC01 Colestyramine
- C10AC02 Colestipol
- C10AC03 Colextran
- C10AC04 Colesevelam
C10AD Niacin and derivatives
- C10AD01 Niceritrol
- C10AD02 Niacin (nicotinic acid)
- C10AD03 Nicofuranose
- C10AD04 Aluminium nicotinate
- C10AD05 Nicotinyl alcohol (pyridylcarbinol)
- C10AD06 Acipimox
C10AX Other lipid modifying agents
- C10AX01 Dextrothyroxine
- C10AX02 Probucol
- C10AX03 Tiadenol
- C10AX04 Benfluorex
- C10AX05 Meglutol
- C10AX06 Omega-3-triglycerides
- C10AX07 Magnesium pyridoxal 5-phosphate glutamate
- C10AX08 Policosanol
- C10AX09 Ezetimibe
C10B Lipid modifying agents, combinations
C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents
- C10BA01 Lovastatin and nicotinic acid
- C10BA02 Simvastatin and ezetimibe
C10BX HMG CoA reductase inhibitors, other combinations
- C10BX01 Simvastatin and acetylsalicylic acid
- C10BX02 Pravastatin and acetylsalicylic acid
- C10BX03 Atorvastatin and amlodipinehu:ATC C10 – A szérum-lipidszintet csökkentő szerekth:ATC รหัส C10
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
